Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
BPC-157: Your Blueprint for Rapid Repair, Renewed Strength, and a Healthier You
Social posts and clinic pages may update faster, but speed does not make them legally controlling
Walk-In Welcome
Call (954) 551-3508 Book Online Here are answers to some of the most common questions patients ask about Wolverine Blend peptide therapy, including BPC-157, TB-500, telehealth consultations, treatment options, and wellness-focused peptide programs in South Florida